PeptideStack
5.2kquestions
20kanswers
220users

Is a 31G needle the right choice for drawing ecnoglutide at 20 mg/mL?

Asked 8 Nov 2024Modified 17 months agoViewed 39k times
28

For reference: a 31G needle · ecnoglutide · 20 mg/mL.

The comparison I want does not seem to exist anywhere in a form I can evaluate.

I have read the arguments for each and they do not engage with each other.

What does each option buy me, and what does it cost me?

needle-gauge
needle-gauge

Gauge and length selection, the trade-off between draw time and tissue trauma, coring risk with larger-bore needles, and why a fixed-needle…

91 questions
injection-technique
injection-technique

Technique questions: angle, pinch versus flat, aspiration, injection speed, air bubbles, and the handling steps that determine whether you deliver…

96 questions
dead-space
dead-space

The volume trapped in the syringe hub and needle after the plunger bottoms out. It is small in absolute terms and large as a fraction of a small…

117 questions
ecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

223 questions
shareeditfollowflag
AP
askedarea_percent9.9k168 Nov 2024

5 Answers

Sorted by votes
68

At 20 mg/mL a 1 mg dose is 0.05 mL — 5 units on a U-100 barrel — and no needle gauge changes that number. Gauge changes three other things: how long the draw takes, how much stays behind in the hub, and how much rubber you core out of the stopper. On the 31G scale a larger number is a finer needle, so a 31G needle is fine enough that a viscous solution draws slowly and a hurried draw pulls bubbles. If you are drawing 5 units at a time, the dead space matters more than the bore: a fixed-needle barrel loses microlitres, a luer hub loses tens of them, and at 20 mg/mL each microlitre is 20 µg.

Answer first: use the largest bore you tolerate for drawing and the smallest for injecting, because the two operations have opposite requirements.

Flow through a needle scales with the fourth power of the internal radius under the Hagen–Poiseuille relation. Halving the radius reduces flow sixteen-fold at the same pressure, which is why a 31G needle draws so much more slowly than a 21G.

Concentration and unit conversion at a glance

VialDiluentConcentration0.25 mg0.5 mg1 mg2.5 mg
5 mg1 mL5 mg/mL5 u10 u20 u50 u
5 mg2 mL2.5 mg/mL10 u20 u40 u100 u
10 mg1 mL10 mg/mL2.5 u5 u10 u25 u
10 mg2 mL5 mg/mL5 u10 u20 u50 u
10 mg3 mL3.33 mg/mL7.5 u15 u30 u75 u

Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.

Drawing a viscous or foamy solution through a fine needle takes long enough that people rush the plunger, which causes more foaming. Using a wider drawing needle is the fix.

Coring risk as a function of needle gauge and insertion technique is documented in pharmacy compounding guidance.

Big to draw, small to inject, never the same one twice.

shareimprove this answerflag
TM
answeredthermal_mass13k1710 Dec 2024
7The arithmetic checks out. I ran the same numbers and got the same result. – Dr_Signe_Baldursdottir 7 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
47

The honest answer is that injection gauge is a comfort decision and drawing gauge is a stopper-coring decision.

Stopper coring — punching a disc of rubber into the solution — is a large-bore phenomenon. An 18G or 21G needle inserted straight and fast is the classic way to do it; inserting at a slight angle with the bevel up reduces the risk.

Put another way, a 30G or 31G needle through a butyl stopper leaves a track that reseals, which is why fine-gauge repeated entry is tolerable and coarse-gauge repeated entry is not.

Butyl rubber closures are specified for resealing after piercing up to a stated gauge, which is the basis for the fine-gauge repeated-entry practice.

Angle the bevel and insert gently to avoid coring the stopper.

shareimprove this answerflag
TA
answeredtri_gly_ala24k3829 Nov 2024
33

Concretely, the relevant physics is the fourth-power dependence of flow on radius, which makes small gauge differences enormous in practice.

For injecting, 29G to 31G is the usual range and the difference in perceived discomfort between them is small. Needle length matters more than gauge for comfort at these volumes.

Very fine needles are more prone to bending and to blocking with any particulate, which is a practical argument for inspecting the solution before drawing.

Flow goes as the fourth power of radius. That is why the difference feels so large.

shareimprove this answerflag
SC
answeredstopper_core28k12718 Nov 2024
27

In practice, coring the stopper with a large-bore needle is the risk at the drawing end, and it is real.

Typical outer diameters: 21G is about 0.82 mm, 23G about 0.64 mm, 25G about 0.51 mm, 29G about 0.34 mm and 31G about 0.26 mm. The gauge number and the diameter move in opposite directions.

The Hagen–Poiseuille relation gives flow proportional to the fourth power of radius, which is the quantitative basis for every gauge recommendation here.

Length affects comfort more than gauge does at these volumes.

shareimprove this answerflag
CO
answeredcoldbox941k1387 Mar 2025
21

Worth being precise here: this is a straightforward answer that people over-complicate because the numbering is counter-intuitive.

Fixed-needle insulin syringes are supplied in 29G to 31G and cannot be swapped for drawing, which is the trade-off against their much lower dead space.

The caveat is that no gauge choice makes a non-sterile preparation safe, and research-use compounds are not approved for human use.

Gauge numbers run backwards. Higher number, thinner needle.

shareimprove this answerflag
DV
answereddead_volume56k4824 Jan 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.